#DYK that #Pathology supplies a majority of a medical record? On #CancerCast, Dr. Amy Chadburn of Weill Cornell Medicine Pathology explains the role pathologists play in #cancer care to help solid tumor & #BloodCancer patients get accurate diagnoses and treatment plans: bit.ly/3JF7ViE

Dr. Jia Ruan explains recent and ongoing #ClinicalTrials evaluating treatment combinations for elderly and/or high-risk patients with mantle cell #lymphoma (#MCL) from Great Debates #GDUHem: bit.ly/4cVkbZz

Hear Dr. John Allan’s thoughts on if chemo-immunotherapy has a role in the treatment of chronic lymphocytic #leukemia (#CLL) via the Lymphoma, Leukemia & Myeloma Congress: bit.ly/3VW7U12

Dr. John Allan compares the use of different Bruton’s tyrosine kinase (BTK) inhibitors for patients with chronic lymphocytic #leukemia (#CLL): bit.ly/43Xk6kd (cc: Lymphoma, Leukemia & Myeloma Congress)

WATCH: Dr. Jia Ruan gives insight into the latest in the mantle cell #lymphoma (#MCL) treatment space, including the comparison between novel therapy combinations and traditional chemoimmunotherapy bit.ly/49CGS1R

WATCH: Dr. John Allan shares the latest treatment updates for chronic lymphocytic leukemia (#CLL), including #research on the use of Bruton’s tyrosine kinase (BTK) inhibitor combinations bit.ly/3ITxyf5

LISTEN: Dr. Sarah Rutherford joined the OncLive.com The Blood Club #podcast to discuss a #ClinicalTrial evaluating a drug combination for older patients with #HodgkinLymphoma bit.ly/49OISEf

This #ClinicalTrialsDay, team members Weill Cornell Medicine NewYork-Presbyterian highlight how we’re making a difference through #ClinicalTrials. So proud of the #ClinicalResearch and behind-the-scenes teamwork moving the field forward. Thanks to all the volunteers who participate in #research!

At the Great Debates #GDUHem, Dr. Peter Martin participated in a session discussing when chimeric antigen receptor (CAR) T-cell therapy should be used for #FollicularLymphoma patients: bit.ly/49MpS9r

Glad to bring to your attention to Dr. Samuel Yamshon's Spotlight event headlining "Strategies to improve CAR T cell fitness in B-cell lymphomas" MedNewsWeek & OncLive.com Date:Monday June 3rd,2024 Time:7:30pm EST/1:30am CET Register here-ow.ly/QNYW50RHo2z

John P. Leonard, MD A testament to the world-class patient care and research you provide WCM Lymphoma

.John P. Leonard, MD discussed the latest targeted therapies for relapsed/refractory #FollicularLymphoma at the 2024 Great Debates #GDUHem. Read the key takeaways: bit.ly/3VP3oRA

LISTEN: Dr. John Allan joined the ReachMD #podcast to talk about personalizing chronic lymphocytic #leukemia (#CLL) care to improve patient outcomes bit.ly/3Loafew

Watch Dr. John Allan talk through a case study where he created a treatment plan for an elderly patient with high-risk chronic lymphocytic #leukemia (#CLL): bit.ly/4bXGbl0

Dr. Peter Martin WCM Lymphoma, and an WCM Englander Institute for Precision Medicine Member, discusses with PBS the journey of one of his patient’s with #mantlecell #lymphoma (#MCL), and the clinical trial that gave him a chance at a cancer-free future. medicalstories.tv/title/mcl/

Our ASCO #CancerCast tradition continues! Dr. Manish Shah (Manish A. Shah) joined me for our annual episode where we delve into the most exciting #ASCO24 #research. From #AI to #immunotherapy & #BiTes, we break down what patients and loved ones should know bit.ly/3WNlPql

NIH Grant Will Support Lymphoma Research | Newsroom | Weill Cornell Medicine Thrilled that our P01 is now active! Congrats to everyone on our teams ⁦WCM Lymphoma & ⁦MD Anderson Cancer Center⁩, especially ⁦Leandro Cerchietti⁩! news.weill.cornell.edu/news/2024/08/n…

A new $12.5 million NIH grant for lymphoma research is the result of a team collaboration led by Dr. Leandro Cerchietti (Leandro Cerchietti) in our #HemOnc division & Dr. Christopher Flowers of MD Anderson Cancer Center bit.ly/3YRARge. Weill Cornell Medicine Meyer Cancer Center WCM Lymphoma Weill Cornell Medicine

ICYMI: Dr. Leandro Cerchietti (Leandro Cerchietti) and collaborators received a $12.4 million NIH grant for an extensive program of basic and translational #research on the biology of diffuse large B-cell #lymphoma (#DLBCL). bit.ly/3yUjeSa

Our #Lymphoma Program and Dr. Peter Martin were recently featured in a PBS story documenting a mantle cell #lymphoma (#MCL) journey and experience with a #ClinicalTrial Weill Cornell Medicine NewYork-Presbyterian: bit.ly/3XjnTX5